Michael LaBarre
Chief Tech/Sci/R&D Officer at HALOZYME THERAPEUTICS, INC.
Net worth: 7 M $ as of 2024-03-30
Profile
Michael J. LaBarre is Chief Technical Officer & Senior Vice President at Halozyme Therapeutics, Inc. In his past career Dr. LaBarre held the position of Director-Analytical & Protein Biochemistry at Biogen, Inc. and Director-Analytical & Formulation Sciences at IDEC Pharmaceuticals Corp. (a subsidiary of Biogen, Inc.) and Vice President-Product Development at Paramount BioSciences LLC. Dr. LaBarre received a doctorate from the University of Arizona and an undergraduate degree from Stony Brook University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-16 | 168,176 ( 0.13% ) | 7 M $ | 2024-03-30 |
Michael LaBarre active positions
Companies | Position | Start |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Former positions of Michael LaBarre
Companies | Position | End |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | 2006-03-31 |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Corporate Officer/Principal | 2003-11-30 |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Corporate Officer/Principal | - |
Training of Michael LaBarre
Stony Brook University | Undergraduate Degree |
University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BIOGEN INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
- Stock Market
- Insiders
- Michael LaBarre